Published by Iain Gilbert on 30th October 2025
(Sharecast News) - Pharmaceutical giant Eli Lilly posted stronger-than-expected third-quarter earnings and revenue on Thursday, fuelled by surging demand for its diabetes drug Mounjaro and weight-loss treatment Zepbound.
URL: http://www.digitallook.com/dl/news/story/35460873/...